David Blank

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

May Faraj, Peter J. Havel, Steve Phélis et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 505 citations · Full text

Medicine, Endocrinology, Surgery +16

Novel Reductant for Determination of Total Plasma Homocysteine

Brian M. Gilfix, David Blank, David S. Rosenblatt · Clinical Chemistry · 1997 · 166 citations · Full text

Life Sciences, Biochemistry, Biochemical Pharmacology +5

Automated determination of urinary creatinine without sample dilution: theory and practice.

Martin Kroll, R Chesler, C Hagengruber et al. · Clinical Chemistry · 1986 · 126 citations

Pharmacy, Nephrology, Analytical Toxicology +9